Skull Base Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) (NCT07209189) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-02-18 |
| Neurosurgical Outcome Network (NCT06724029) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2022-12-05 |
Track Skull Base Tumors automatically
Every clearance here is in the API, with alerts when new ones post.